Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haemocomplettan P in Complex Cardiac Surgery
NCT01124981Phase 3Completed
- Sponsor
- Isala
- Start
- Feb 2011
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Fibrinogen human in fibrinogen deficiency (2 arms), sponsored by Isala. Primary endpoint: Perioperative blood loss at 12 hours. Started Feb 2011; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiency
Beyond the preview
Go deeper on NCT01124981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124981.